Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interventions for hidradenitis suppurativa.
Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, Hood K, Burton T, Kerdel F, Garner SE, Piguet V. Ingram JR, et al. Among authors: kerdel f. Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD010081. doi: 10.1002/14651858.CD010081.pub2. Cochrane Database Syst Rev. 2015. PMID: 26443004 Free PMC article. Review.
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB. Kimball AB, et al. Among authors: kerdel f. N Engl J Med. 2016 Aug 4;375(5):422-34. doi: 10.1056/NEJMoa1504370. N Engl J Med. 2016. PMID: 27518661 Free article. Clinical Trial.
Emerging drugs for the treatment of hidradenitis suppurativa.
Folkes AS, Hawatmeh FZ, Wong A, Kerdel FA. Folkes AS, et al. Expert Opin Emerg Drugs. 2020 Sep;25(3):201-211. doi: 10.1080/14728214.2020.1787984. Epub 2020 Jul 22. Expert Opin Emerg Drugs. 2020. PMID: 32667213 Review.
Infliximab for hidradenitis suppurativa.
Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Sullivan TP, et al. Among authors: kerdel fa. Br J Dermatol. 2003 Nov;149(5):1046-9. doi: 10.1111/j.1365-2133.2003.05663.x. Br J Dermatol. 2003. PMID: 14632813
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB. Kimball AB, et al. Among authors: kerdel f. Ann Intern Med. 2012 Dec 18;157(12):846-55. doi: 10.7326/0003-4819-157-12-201212180-00004. Ann Intern Med. 2012. PMID: 23247938 Clinical Trial.
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.
Gottlieb A, Natsis NE, Kerdel F, Forman S, Gonzalez E, Jimenez G, Hernandez L, Kaffenberger J, Guido G, Lucas K, Montes D, Gold M, Babcock C, Simard J. Gottlieb A, et al. Among authors: kerdel f. J Invest Dermatol. 2020 Aug;140(8):1538-1545.e2. doi: 10.1016/j.jid.2019.10.024. Epub 2020 Jan 29. J Invest Dermatol. 2020. PMID: 32004568 Free article. Clinical Trial.
237 results